Stay updated on ABTL0812 in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the ABTL0812 in Pancreatic Cancer Clinical Trial page.

Latest updates to the ABTL0812 in Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has removed a citation regarding the anticancer effects of ABTL0812, including an erratum notice.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check36 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about a clinical study on ABTL0812 for pancreatic cancer, while adding references to the study's collaborators and a new revision number.SummaryDifference51%
- Check44 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check51 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check87 days agoChange DetectedThe page has added a reference to a study on the anticancer effects of ABTL0812 in glioblastoma models, while also removing a notice about heavy traffic affecting NLM-NCBI services.SummaryDifference1%
Stay in the know with updates to ABTL0812 in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABTL0812 in Pancreatic Cancer Clinical Trial page.